BRCA1 and 2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter Analysis. - Fedele, Palma; Rizzo, Alessandro; Landriscina, Matteo; Stucci, Stefania Luigia; Morritti, Maria; Giuliani, Francesco; Moraca, Lucia; Cairo, Giuseppe; Ardito, Raffaele; Giampaglia, Marianna; Bilancia, Domenico; Melaccio, Assunta; et al. (Journal of Clinical Medicine, 2025)